pirfenidone has been researched along with Bleeding in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chou, W; Glassberg, MK; Lin, CY; Morgenthien, EA; Nathan, SD; Noble, PW; Stauffer, JL | 1 |
DePew, ZS; Dull, SK; Jagan, N; Malesker, MA; Moore, DR; Morrow, LE | 1 |
1 trial(s) available for pirfenidone and Bleeding
Article | Year |
---|---|
Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Atrial Fibrillation; Cardiovascular Agents; Cardiovascular Diseases; Coronary Artery Disease; Female; Hemorrhage; Humans; Idiopathic Pulmonary Fibrosis; Male; Middle Aged; Pyridones; Retrospective Studies; Risk Factors; Treatment Outcome; Warfarin | 2019 |
1 other study(ies) available for pirfenidone and Bleeding
Article | Year |
---|---|
Diffuse Alveolar Hemorrhage Following Pirfenidone Initiation.
Topics: Aged; Aged, 80 and over; Female; Hemorrhage; Humans; Idiopathic Pulmonary Fibrosis; Lung; Male; Pyridones | 2020 |